Immune to Cancer: The CRI Blog
-
How Immunotherapy for Esophageal Cancer is Making an Impact
Dr. Deirdre Cohen discusses recent advances in immunotherapy for esophageal cancer, including biomarkers, checkpoint inhibitors, cell-based therapies,…
-
Head and Neck Cancer Awareness Month: 2020 Immunotherapy Research Update
HPV’s connection to head and neck cancer, treatment options, side effects, and how we’re working toward a…
-
Defining Resistance to Treatment with Anti-PD-1/PD-L1 Immunotherapy
CRI's Vanessa M. Lucey, Ph.D, MBA, helps guide the design and analysis of future clinical trials involving…
-
CRI Scientists Fighting the Novel Coronavirus Pandemic
CRI’s focus on immunology research—while primarily aimed at curing cancer—also has contributed to advances in the treatment…
-
Meet the Five Inaugural Lloyd J. Old STARs
We spoke with the five inaugural CRI Lloyd J. Old STARs to learn more about their work…
-
Vaccine-Chemo Combo Shows Promise in Treating Advanced, HPV-Associated Cervical Cancer
Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with…
-
COVID-19 and the Immune System: How Cancer Research Can Help Rein in the Novel Coronavirus Pandemic
Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.
-
COVID-19 y el sistema inmunitario: cómo la investigación del cáncer puede ayudar a frenar la pandemia del nuevo coronavirus
Las lecciones aprendidas de la investigación sobre inmunoterapia contra el cáncer pueden ayudar a frenar la pandemia…
-
Life with Cancer During the Novel Coronavirus Pandemic (COVID-19)
Drew Griffin, a colorectal cancer survivor, discusses his experience in Seattle and his advice for cancer patients…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.